Intertrust Technologies Corporation and Haystack Bio, a pioneer in immuno-technologies, announced that Haystack will use Intertrust’s Genecloud platform for trusted healthcare analytics. Under the partnership, Haystack Bio will use Genecloud to securely store, analyze and share data collected from Haystack Bio’s advanced single-cell discovery platform. 

Read more at Pharmabiz.com